Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $3.12 Million - $3.65 Million
-52,728 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $5,200 - $5,663
84 Added 0.16%
52,728 $3.52 Million
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $2.81 Million - $3.16 Million
-47,338 Reduced 47.35%
52,644 $3.32 Million
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $125,584 - $142,310
-2,175 Reduced 2.13%
99,982 $6.2 Million
Q3 2020

Nov 03, 2020

BUY
$57.43 - $63.64 $1.1 Million - $1.22 Million
19,101 Added 23.0%
102,157 $6.16 Million
Q2 2020

Aug 04, 2020

BUY
$54.82 - $64.09 $109 - $128
2 Added 0.0%
83,056 $4.88 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $988,830 - $1.44 Million
-21,311 Reduced 20.42%
83,054 $4.63 Million
Q4 2019

Jan 21, 2020

SELL
$49.21 - $64.19 $65,842 - $85,886
-1,338 Reduced 1.27%
104,365 $6.7 Million
Q3 2019

Oct 11, 2019

SELL
$42.77 - $50.71 $1.75 Million - $2.08 Million
-41,025 Reduced 27.96%
105,703 $5.36 Million
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $148,361 - $164,055
-3,325 Reduced 2.22%
146,728 $6.65 Million
Q1 2019

Apr 23, 2019

BUY
$45.12 - $53.8 $812 - $968
18 Added 0.01%
150,053 $7.16 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $1.37 Million - $1.78 Million
28,100 Added 23.05%
150,035 $7.8 Million
Q3 2018

Nov 02, 2018

SELL
$55.19 - $62.25 $1.67 Million - $1.89 Million
-30,300 Reduced 19.9%
121,935 $7.57 Million
Q2 2018

Aug 01, 2018

SELL
$50.53 - $62.98 $46,740 - $58,256
-925 Reduced 0.6%
152,235 $8.43 Million
Q1 2018

May 01, 2018

SELL
$59.92 - $68.98 $272,036 - $313,169
-4,540 Reduced 2.88%
153,160 $9.69 Million
Q4 2017

Feb 06, 2018

SELL
$59.94 - $65.35 $1.49 Million - $1.62 Million
-24,775 Reduced 13.58%
157,700 $9.66 Million
Q3 2017

Oct 31, 2017

BUY
$55.23 - $63.74 $10.1 Million - $11.6 Million
182,475
182,475 $11.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Decatur Capital Management, Inc. Portfolio

Follow Decatur Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Decatur Capital Management, Inc. with notifications on news.